Karyopharm Therapeutics Inc. (KPTI) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Stock Price

$0.86

-$0.08

(-8.21%)

Day's range

$0.85

$0.93

Consensus Rating

Hold

Based on 28 Analyst Ratings
Consensus Price Target

$7.33

752.33% Upside

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
06/10/2024	RBC Capital	Brian Abrahams	$3.00	$0.95	215.42%

Karyopharm Therapeutics Inc. Frequently Asked Questions

What analysts cover Karyopharm Therapeutics Inc.?

Karyopharm Therapeutics Inc. has been rated by research analysts at RBC Capital, Leerink Partners, Robert W. Baird in the past 90 days.

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.